Actinium Pharmaceuticals (ATNM) Stock Chart & Stock Price History $1.55 +0.06 (+4.03%) Closing price 04:00 PM EasternExtended Trading$1.56 +0.00 (+0.32%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Actinium Pharmaceuticals Stock Price Performance 5 Day Performance+18.32%1 Month Performance+1.97%3 Month Performance+33.62%6 Month Performance-9.36%Year-To-Date Performance+23.02%1 Year Performance-79.87% Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ATNM Stock Chart for Friday, May, 2, 2025 ATNM Chart by TradingView Actinium Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/01/2025$1.52$1.49-1.97%$1.54$1.43317,965 shs$46.48 million04/30/2025$1.43$1.52+6.29%$1.52$1.35517,309 shs$47.42 million04/29/2025$1.30$1.43+10.00%$1.57$1.30810,625 shs$44.61 million04/28/2025$1.31$1.30-0.76%$1.43$1.25552,393 shs$40.56 million04/25/2025$1.27$1.31+3.15%$1.36$1.21321,407 shs$40.87 million04/24/2025$1.30$1.27-2.31%$1.40$1.26339,430 shs$39.62 million04/23/2025$1.38$1.30-5.80%$1.45$1.27320,486 shs$40.56 million04/22/2025$1.20$1.38+15.00%$1.39$1.23578,411 shs$43.05 million04/21/2025$1.21$1.20-0.83%$1.21$1.17259,502 shs$37.44 million04/18/2025$1.21$1.21$1.24$1.17323,422 shs$37.75 million Get the Latest News and Ratings for ATNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 04/17/2025$1.25$1.21-3.20%$1.24$1.17323,422 shs$37.75 million04/16/2025$1.26$1.25-0.79%$1.26$1.19188,035 shs$39.00 million04/15/2025$1.32$1.26-4.55%$1.34$1.18393,609 shs$39.31 million04/14/2025$1.30$1.32+1.54%$1.34$1.24357,781 shs$41.18 million04/11/2025$1.15$1.30+13.04%$1.30$1.13259,531 shs$40.56 million04/10/2025$1.26$1.15-8.73%$1.27$1.15326,229 shs$35.88 million04/09/2025$1.21$1.26+4.13%$1.35$1.14580,586 shs$39.31 million04/09/2025$1.21$1.26+4.13%$1.35$1.14580,586 shs$39.31 million04/08/2025$1.22$1.21-0.82%$1.30$1.20247,605 shs$37.75 million04/08/2025$1.22$1.21-0.82%$1.30$1.20247,605 shs$37.75 million04/07/2025$1.29$1.22-5.43%$1.35$1.16597,617 shs$38.06 million04/04/2025$1.39$1.29-7.19%$1.40$1.27304,206 shs$40.24 million04/03/2025$1.52$1.39-8.55%$1.50$1.36291,751 shs$43.36 million04/02/2025$1.49$1.52+2.01%$1.55$1.42352,271 shs$47.42 million04/01/2025$1.61$1.49-7.45%$1.66$1.41699,711 shs$46.48 million Related Companies ProQR Therapeutics Stock Price Chart Tango Therapeutics Stock Price Chart 4D Molecular Therapeutics Stock Price Chart Tiziana Life Sciences Stock Price Chart LifeVantage Stock Price Chart Larimar Therapeutics Stock Price Chart Nanobiotix Stock Price Chart Puma Biotechnology Stock Price Chart Cybin Stock Price Chart Aclaris Therapeutics Stock Price Chart Receive ATNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Actinium Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:ATNM) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinium Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Actinium Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ATNM Stock Free ATNM Stock Alerts